(Q24240537)

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

A stable prostacyclin analogue (iloprost) in the treatment of ischaemic ulcers of the lower limb. A Scandinavian-Polish placebo controlled, randomised multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

Comparison of beraprost and ticlopidine in Chinese patients with chronic peripheral arterial occlusion: a multicenter, single-blind, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

Prostaglandin E1 versus lumbar sympathectomy in the treatment of peripheral arterial occlusive disease: randomised study of 86 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

Intermittent claudication. Current results of nonoperative management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

Prostanoid drug therapy for peripheral arterial occlusive disease--the European experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

Medical treatment of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascul

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

Arterial gene transfer of naked DNA for therapeutic angiogenesis: early clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

Arteriosclerosis Obliterans: Review of 520 Cases with Special Reference to Pathogenic and Prognostic Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

Critical limb ischemia: definition and natural history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

Prostanoids for intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

Prostaglandin E1 in severe lower limb ischaemia: A double-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

7 January 2021

The Effect of Ciprostene in Patients with Peripheral Vascular Disease (PVD) Characterized by Ischemic Ulcers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

7 January 2021

EPOPROSTENOL (PROSTACYCLIN) AND SEVERE ARTERIAL DISEASE

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

7 January 2021

Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

7 January 2021

[Iloprost, a stable prostacyclin derivative, in stage 4 arterial occlusive disease. A placebo-controlled multicenter study]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

7 January 2021

Changes in peripheral blood pressures after five years of follow-up in non-operated patients with intermittent claudication

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

7 January 2021

Fate in intermittent claudication: outcome and risk factors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

7 January 2021

Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

7 January 2021

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006544.PUB2

7 January 2021

10.1002/14651858.CD006544.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2290757

OpenCitations bibliographic resource ID

2290757

1 reference